查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602646

过敏治疗药物市场：按类型、治疗类型、给药途径、分销管道 - 全球预测 2025-2030

Allergy Treatment Market by Type (Asthma, Eye Allergy, Food Allergy), Treatment Type (Anti-Allergy Drugs, Immunotherapy), Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年过敏治疗药物市值为291.5亿美元，预计到2024年将达到315.6亿美元，复合年增长率为8.65%，到2030年将达到521.2亿美元。

过敏药物市场包括多种药物，包括抗组织胺、皮质类固醇和免疫疗法，以及针对呼吸系统、皮肤和食物过敏的先进生技药品和新型治疗方法。由于都市化、污染和生活方式的改变导致发病率上升，迫切需要强有力的过敏治疗，从而推动了对有效管理解决方案的需求。过敏疗法的应用对于缓解鼻塞、皮肤发炎和过敏反应等症状以及透过减少住院治疗来提高生活品质至关重要。最终用途的范围多种多样，包括诊所、医院和家庭，凸显了这些治疗方案的灵活性和可近性。市场成长受到意识的提高、新兴国家医疗保健支出的增加以及新产品的持续研究的显着影响。个人化医疗和生技药品领域的潜在商机激增，尤其是提供标靶治疗策略的单株抗体。用于即时过敏监测和远端医疗服务的可穿戴设备等数位健康创新也开闢了新的途径。市场格局面临先进治疗成本高昂、监管环境严格以及医疗保健取得方面的地区差异等因素的挑战，这些都可能限製成长。创新的最佳领域是开发具有成本效益和非侵入性的替代方案，利用生物技术提高疗效，并将人工智慧和机器学习相结合以进行预测诊断和个人化治疗计划。市场是动态的，其特点是技术快速进步和消费者偏好不断变化，需要不断适应才能持续成功。企业应投资于研发伙伴关係和策略联盟，以利用新兴趋势并解决未满足的需求。总体而言，如果有效管理可及性和监管合规性方面的挑战，那么生物技术和数位健康整合的积极主动方法就有可能实现显着成长。

主要市场统计
基准年[2023] 291.5亿美元
预测年份 [2024] 315.6亿美元
预测年份 [2030] 521.2亿美元
复合年增长率（%） 8.65%

市场动态：揭示快速发展的过敏药物市场的关键市场洞察

供需的动态交互作用正在改变过敏药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 过敏性疾病在人群中的盛行率正在增加
    • 对非处方药和网路药局的偏好日益增加
  • 市场限制因素
    • 过敏药物原料成本波动
  • 市场机会
    • 积极进行研究活动，引进先进的过敏治疗方法
    • 远端医疗和虚拟医疗服务的出现
  • 市场挑战
    • 与过敏药物生产相关的品质问题

波特五力：驾驭过敏药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解过敏药物市场的外部影响

外部宏观环境因素在影响过敏治疗药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解过敏药物市场的竞争状况

过敏治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵过敏治疗市场供应商的绩效评估

FPNV 定位矩阵是评估过敏治疗药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了过敏治疗药物市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，过敏药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中过敏性疾病盛行率上升
      • 对非处方药和网路药局的偏好日益增加
    • 抑制因素
      • 过敏药物所用原料成本的变化
    • 机会
      • 大力研究旨在引进先进的过敏治疗方法
      • 远端医疗和虚拟医疗服务的出现
    • 任务
      • 与生产过敏药物相关的品质问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章过敏治疗药物市场：依类型

  • 气喘
  • 眼睛过敏
  • 食物过敏
  • 鼻炎
  • 皮肤过敏

第七章依治疗类型分類的过敏治疗药物市场

  • 抗过敏药
  • 免疫疗法

第八章过敏药物市场：依给药途径分类

  • 鼻腔
  • 口服
  • 胃肠外的

第九章过敏治疗药物市场：依通路分类

  • 离线
    • 药局
    • 零售药房
  • 在线的

第十章北美及南美过敏药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太过敏药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲过敏药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ALK-Abello A/S
  • Alladapt Immunotherapeutics, Inc.
  • Allergopharma GmbH & Co. KG
  • Allergy Therapeutics PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • ClostraBio, Inc.
  • Connote Healthcare
  • DBV Technologies
  • GentiBio, Inc.
  • GlaxoSmithKline PLC
  • HollisterStier Allergy
  • IgGenix, Inc.
  • Indoor Biotechnologies, Inc.
  • Inimmune
  • Monark Biocare Private Limited
  • OptiNose US, Inc.
  • Reacta Healthcare
  • Sanofi SA
  • Stallergenes Greer International AG
  • Taiho Pharmaceutical Co., Ltd.
  • Third Harmonic Bio
  • Trillium Health Care Products, Inc
  • Upstream Bio, Inc.
Product Code: MRR-C002B1C99846

The Allergy Treatment Market was valued at USD 29.15 billion in 2023, expected to reach USD 31.56 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 52.12 billion by 2030.

The allergy treatment market encompasses a broad scope that includes pharmaceuticals such as antihistamines, corticosteroids, and immunotherapy, along with advanced biologics and novel therapeutics addressing respiratory, dermal, and food allergies. The necessity for robust allergy treatments is underscored by rising incidence rates fueled by urbanization, pollution, and lifestyle changes, increasing the demand for effective management solutions. Applications of allergy treatments are vital for enhancing quality of life by alleviating symptoms like congestion, skin irritation, and anaphylaxis, and reducing hospital admissions. End-use scope spans across clinics, hospitals, and home settings, highlighting the flexibility and accessibility of these treatment options. Market growth is significantly influenced by heightened awareness, increased healthcare spending in emerging economies, and ongoing research yielding novel products. There's a surge in potential opportunities within personalized medicine and biologics, particularly monoclonal antibodies offering targeted treatment strategies-segments poised for expansion as consumers seek tailored therapeutics. Digital health innovations such as wearable devices for real-time allergy monitoring and telehealth services are also opening new pathways. Challenges in the market include high costs of advanced treatments, stringent regulatory landscapes, and regional disparities in healthcare access that could restrain growth. Best areas for innovation focus on developing cost-effective, non-invasive alternatives, leveraging biotechnology to enhance efficacy, and integrating AI and machine learning for predictive diagnostics and personalized treatment plans. The market is dynamic, characterized by rapid technological advancements and shifting consumer preferences, which necessitate continual adaptation for sustained success. Companies should invest in R&D partnerships and strategic collaborations to leverage emerging trends and address unmet needs. Overall, proactive approaches in biotechnology and digital health integration could unlock significant growth, provided challenges related to accessibility and regulatory compliance are effectively managed.

KEY MARKET STATISTICS
Base Year [2023] USD 29.15 billion
Estimated Year [2024] USD 31.56 billion
Forecast Year [2030] USD 52.12 billion
CAGR (%) 8.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Treatment Market

The Allergy Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of allergic conditions among population
    • Growing preferences toward OTC and online pharmacy
  • Market Restraints
    • Fluctuating cost of raw materials used in allergy medications
  • Market Opportunities
    • Robust research activities to introduce advanced allergic treatments
    • Emergence of telemedicine and virtual healthcare services
  • Market Challenges
    • Quality issues associated with production of allergy medicines

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Treatment Market

A detailed market share analysis in the Allergy Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Treatment Market

A strategic analysis of the Allergy Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Treatment Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Alladapt Immunotherapeutics, Inc., Allergopharma GmbH & Co. KG, Allergy Therapeutics PLC, Bayer AG, Bristol-Myers Squibb Company, ClostraBio, Inc., Connote Healthcare, DBV Technologies, GentiBio, Inc., GlaxoSmithKline PLC, HollisterStier Allergy, IgGenix, Inc., Indoor Biotechnologies, Inc., Inimmune, Monark Biocare Private Limited, OptiNose US, Inc., Reacta Healthcare, Sanofi S.A., Stallergenes Greer International AG, Taiho Pharmaceutical Co., Ltd., Third Harmonic Bio, Trillium Health Care Products, Inc, and Upstream Bio, Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Asthma, Eye Allergy, Food Allergy, Rhinitis, and Skin Allergy.
  • Based on Treatment Type, market is studied across Anti-Allergy Drugs and Immunotherapy.
  • Based on Route of Administration, market is studied across Nasal, Oral, and Parenteral.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Drug Stores and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of allergic conditions among population
      • 5.1.1.2. Growing preferences toward OTC and online pharmacy
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuating cost of raw materials used in allergy medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research activities to introduce advanced allergic treatments
      • 5.1.3.2. Emergence of telemedicine and virtual healthcare services
    • 5.1.4. Challenges
      • 5.1.4.1. Quality issues associated with production of allergy medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Allergy Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Asthma
  • 6.3. Eye Allergy
  • 6.4. Food Allergy
  • 6.5. Rhinitis
  • 6.6. Skin Allergy

7. Allergy Treatment Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Anti-Allergy Drugs
  • 7.3. Immunotherapy

8. Allergy Treatment Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Nasal
  • 8.3. Oral
  • 8.4. Parenteral

9. Allergy Treatment Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Drug Stores
    • 9.2.2. Retail Pharmacies
  • 9.3. Online

10. Americas Allergy Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Allergy Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ALK-Abello A/S
  • 2. Alladapt Immunotherapeutics, Inc.
  • 3. Allergopharma GmbH & Co. KG
  • 4. Allergy Therapeutics PLC
  • 5. Bayer AG
  • 6. Bristol-Myers Squibb Company
  • 7. ClostraBio, Inc.
  • 8. Connote Healthcare
  • 9. DBV Technologies
  • 10. GentiBio, Inc.
  • 11. GlaxoSmithKline PLC
  • 12. HollisterStier Allergy
  • 13. IgGenix, Inc.
  • 14. Indoor Biotechnologies, Inc.
  • 15. Inimmune
  • 16. Monark Biocare Private Limited
  • 17. OptiNose US, Inc.
  • 18. Reacta Healthcare
  • 19. Sanofi S.A.
  • 20. Stallergenes Greer International AG
  • 21. Taiho Pharmaceutical Co., Ltd.
  • 22. Third Harmonic Bio
  • 23. Trillium Health Care Products, Inc
  • 24. Upstream Bio, Inc.

LIST OF FIGURES

  • FIGURE 1. ALLERGY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ALLERGY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALLERGY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ALLERGY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ALLERGY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALLERGY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALLERGY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALLERGY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY EYE ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY SKIN ALLERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALLERGY TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ALLERGY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALLERGY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ALLERGY TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 235. ALLERGY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. ALLERGY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023